BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17363688)

  • 1. Increased expression of glutathione reductase in macrophages decreases atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice.
    Qiao M; Kisgati M; Cholewa JM; Zhu W; Smart EJ; Sulistio MS; Asmis R
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1375-82. PubMed ID: 17363688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grb2 is required for atherosclerotic lesion formation.
    Proctor BM; Ren J; Chen Z; Schneider JG; Coleman T; Lupu TS; Semenkovich CF; Muslin AJ
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1361-7. PubMed ID: 17363695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
    Caravaggio JW; Hasu M; MacLaren R; Thabet M; Raizman JE; Veinot JP; Marcel YL; Milne RW; Whitman SC
    Cardiovasc Pathol; 2013; 22(6):458-64. PubMed ID: 23684818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
    Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
    Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Ng CJ; Bourquard N; Hama SY; Shih D; Grijalva VR; Navab M; Fogelman AM; Reddy ST
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1368-74. PubMed ID: 17446441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
    Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
    Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F
    Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
    Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
    Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice.
    Zhang D; Fang P; Jiang X; Nelson J; Moore JK; Kruger WD; Berretta RM; Houser SR; Yang X; Wang H
    Circ Res; 2012 Jun; 111(1):37-49. PubMed ID: 22628578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
    Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP
    Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
    Valenta DT; Ogier N; Bradshaw G; Black AS; Bonnet DJ; Lagrost L; Curtiss LK; Desrumaux CM
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
    Rozenberg I; Sluka SH; Rohrer L; Hofmann J; Becher B; Akhmedov A; Soliz J; Mocharla P; Borén J; Johansen P; Steffel J; Watanabe T; Lüscher TF; Tanner FC
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):923-30. PubMed ID: 20203300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
    Potteaux S; Combadière C; Esposito B; Lecureuil C; Ait-Oufella H; Merval R; Ardouin P; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1858-63. PubMed ID: 16763157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of macrophages in glucocorticoid driven vascular calcification in a mouse-model of atherosclerosis.
    Preusch MR; Rattazzi M; Albrecht C; Merle U; Tuckermann J; Schütz G; Blessing E; Zoppellaro G; Pauletto P; Krempien R; Rosenfeld ME; Katus HA; Bea F
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2158-64. PubMed ID: 18787189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
    Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y
    Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development.
    Georgiadi A; Wang Y; Stienstra R; Tjeerdema N; Janssen A; Stalenhoef A; van der Vliet JA; de Roos A; Tamsma JT; Smit JW; Tan NS; Müller M; Rensen PC; Kersten S
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1529-37. PubMed ID: 23640487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.
    Pennings M; Hildebrand RB; Ye D; Kunne C; Van Berkel TJ; Groen AK; Van Eck M
    Cardiovasc Res; 2007 Oct; 76(1):175-83. PubMed ID: 17560559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis.
    Hamers AA; Vos M; Rassam F; Marinković G; Kurakula K; van Gorp PJ; de Winther MP; Gijbels MJ; de Waard V; de Vries CJ
    Circ Res; 2012 Feb; 110(3):428-38. PubMed ID: 22194623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.